Newron Pharmaceuticals S.p.A. 0QOI.L
0QOI.L
Newron Pharmaceuticals S.p.A. 0RRB.L
DocMorris AG 0QP7.L
COLTENE Holding AG 0QQM.L
IVF Hartmann Holding AG 0QLX.L
Metall Zug AG 0QN1.L
Santhera Pharmaceuticals Holding AG 0QXX.L
Molecular Partners AG 0QON.L
Ascom Holding AG 0QKQ.L
Relief Therapeutics Holding AG 0QNA.L
Basilea Pharmaceutica AG
Newron Pharmaceuticals S.p.A. 0RRB.L
DocMorris AG 0QP7.L
COLTENE Holding AG 0QQM.L
IVF Hartmann Holding AG 0QLX.L
Metall Zug AG 0QN1.L
Santhera Pharmaceuticals Holding AG 0QXX.L
Molecular Partners AG 0QON.L
Ascom Holding AG 0QKQ.L
Relief Therapeutics Holding AG 0QNA.L
Basilea Pharmaceutica AG
Performance
| Periode | 0QOI.L | 0RRB.L | 0QP7.L | 0QQM.L | 0QLX.L | 0QN1.L | 0QXX.L | 0QON.L | 0QKQ.L | 0QNA.L |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 122.76 % | -38.43 % | -25.49 % | -14.20 % | -20.80 % | -27.52 % | -12.31 % | 20.33 % | 14.05 % | 19.68 % |
| YTD | 63.98 % | -69.86 % | -10.12 % | -8.72 % | -31.43 % | -30.38 % | -35.67 % | -14.25 % | -36.11 % | 17.51 % |
| 1Y | 60.88 % | -80.41 % | -13.22 % | -3.55 % | -36.51 % | 14.19 % | -47.42 % | -32.02 % | -54.75 % | 7.99 % |
| 3Y | 483.85 % | -76.74 % | -41.02 % | 19.82 % | -57.73 % | 57.47 % | -56.49 % | -39.33 % | -73.96 % | 10.05 % |
| 5Y | 738.90 % | -98.30 % | -35.47 % | -15.00 % | -38.78 % | -65.70 % | -81.20 % | -68.83 % | -97.82 % | 11.33 % |
| 10Y | -47.35 % | -98.30 % | -30.63 % | -26.49 % | -81.03 % | -98.96 % | -86.43 % | -79.37 % | -97.82 % | 11.33 % |
| From the beginning | -13.56 % | -98.30 % | -30.63 % | -26.49 % | -81.03 % | -73.45 % | -87.28 % | -79.37 % | -97.82 % | 11.33 % |